SCHEMBL7239787

SCHEMBL7239787

Cc1ccnc(N2CCC(NC(=O)OC(C)(C)C)C2)c1

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SYK P43405 2/20 0.56
PDE10A Q9Y233 2/20 0.51
SUV39H2 Q9H5I1 6/20 0.50
MAP4K4 O95819 2/20 0.50
CKS1B P61024 1/20 0.50
SKP1 P63208 1/20 0.50
SKP2 Q13309 1/20 0.50
BTK Q06187 2/20 0.48
JAK3 P52333 1/20 0.48
ITGB2 P05107 1/20 0.47
ICAM1 P05362 1/20 0.47
ITGAL P20701 1/20 0.47
CTSK P43235 2/20 0.46
PIM1 P11309 1/20 0.46
PIM3 Q86V86 1/20 0.46
PIM2 Q9P1W9 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29849700 0.88 SUV39H2 (0.52) SYKPDE10ASUV39H2MAP4K4CKS1B
SCHEMBL7846512 0.86 SYK (0.47) SYKPDE10ASUV39H2MAP4K4CKS1B
SCHEMBL1351791 0.86 SYK (0.64) SYKPDE10ASUV39H2MAP4K4CKS1B
SCHEMBL1351789 0.86 SYK (0.64) SYKPDE10ASUV39H2MAP4K4CKS1B
SCHEMBL7847483 0.86 SYK (0.46) SYKPDE10ASUV39H2MAP4K4CKS1B
SCHEMBL20051576 0.85 USP30 (0.58) SYKPDE10ASUV39H2MAP4K4CKS1B
SCHEMBL4278748 0.85 GPBAR1 (0.47) SYKITGB2ICAM1ITGAL
SCHEMBL18228315 0.84 PDE10A (0.55) SYKPDE10ASUV39H2MAP4K4CKS1B
SCHEMBL1401964 0.84 GPR119 (0.58) SYKPDE10AMAP4K4CKS1BSKP1
SCHEMBL1401967 0.84 GPR119 (0.58) SYKPDE10AMAP4K4CKS1BSKP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6521643-B1 Prevention and/or treatment of nitric oxide synthasey medi-ated diseases such as adult respiratory distress syndrome, myocarditis, synovitis, septic shock, diabetes, ulcerative colitis, cerebral infarction, osteoarthritis FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-02-18 US disclosed
EP-1157022-A1 PYRIDINE COMPOUNDS AND THEIR PHARMACEUTICAL USE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-28 EP disclosed
WO-2000049015-A1 PYRIDINE COMPOUNDS AND THEIR PHARMACEUTICAL USE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-08-24 WO disclosed